Transforming the Treatment of Lung Fibrosis through Lung Repair & Regeneration
Автор: Bolton Pulmonary Fibrosis Support Group
Загружено: 2021-11-24
Просмотров: 28
Boehringer Ingelheim scientists are dedicated immunology and respiratory research and development centres, located in the USA and Germany, have extensive R&D expertise in the discovery and clinical validation of novel mechanisms of action. Together with our academic and industry partners, they are working to offer patients and doctors new therapeutic options to treat chronic inflammatory and fibrotic diseases of the lung, gut and skin.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: